Skip to content

TiMing of Intervention in patients with Acute Coronary Syndromes

An International randomised trial of early versus delayed invasive strategies in patients with non-ST segment elevation acute coronary syndromes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN20993046
Enrollment
4000
Registered
2006-11-27
Start date
2005-06-15
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndromes (unstable angina and non-ST segment elevation myocardial infarction) Circulatory System Angina pectoris

Interventions

Early intervention: Coronary angiography and intervention as soon as possible (within 24 hours of randomisation). Delayed intervention: Coronary angiog

Sponsors

Population Health Research Institute (PHRI) (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients presenting or admitted to hospital with symptoms suspected to represent an acute coronary syndrome (unstable angina or MI without persistent ST elevation), i.e. clinical history consistent with new onset, or a worsening pattern, of characteristic ischaemic chest pain or ischaemic symptoms occurring at rest or with minimal activity (lasting longer than five minutes or requiring sublingual nitroglycerin for relief of the pain) 2. Able to randomise within 24 hours of the onset of the most recent episode of symptoms 3. At least two of the three following additional criteria: 3.1. Age more than or equal to 60 years, either sex 3.2. Troponin T or I or creatine kinase - myocardial bands (CK-MB) above the upper limit of normal for the local institution 3.3. Electrocardiogram (ECG) changes compatible with ischaemia (i.e., ST depression at least 1 mm in two contiguous leads or T wave inversion mroe than 3 mm or any dynamic ST shift or transient ST elevation) 4. Written informed consent dated and signed

Exclusion criteria

Exclusion criteria: 1. Age less than 21 years 2. Not a suitable candidate for revascularisation 3. Co-morbid condition with life expectancy less than six months

Design outcomes

Primary

MeasureTime frame
The first occurrence of the composite death/myocardial (re-)infarction/stroke up to day 180.

Secondary

MeasureTime frame
1. The composite of death, myocardial (re-)infarction, stroke, refractory ischaemia or repeat revascularisation at 180 days 2. The first occurrence of any component of the composite of death myocardial infarction and refractory ischaemia until day 14, 30, 90 and at six months (day 180) 3. Stroke at 30 days and 180 days 4. Need for mechanical or pharmacological coronary revascularisation (i.e., percutaneous coronary intervention [PCI], coronary artery bypass graft [CABG], thrombolysis) at days 30, 90 and 180 days

Countries

Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, India, Poland, Romania, Slovakia, Slovenia, Switzerland, United States of America

Contacts

Public ContactBrandi Meeks
brandi@cardio.on.ca+1 (0)905 527 4322 ext. 44818

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026